Radiation Protection Training Course
Course dates
Monday 20 to Friday 24 April 2026
Venue
The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, UK.
Course overview
The course is organised by the Joint Department of Physics of The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research.
The course provides the theoretical background and training necessary for the radiological protection requirements of both ionising and non-ionising radiations used in hospitals. Although derived from an international framework the course content centres on UK Legislation
The main 4 day module (Monday until Thursday) covers the following subject areas: radiation risks, dosimetry, biological effects, instrumentation, legislation, transport, emergencies, and safe practice in the medical uses of ionising radiations. On the afternoon of day 3, delegates will have the opportunity to split into groups according to specialism for focussed discussions and worked examples.
As well as lectures, there will be small informal workshop sessions covering a range of practical issues. The additional (optional) 1 day module on Friday covers non-ionising radiation protection.
The course is at a level suitable for hospital physicists working in the field of radiation protection or those who want to expand their knowledge in this field. It is particularly suitable for those wishing to become Radiation Protection Advisers (RPA) and covers the Basic Underpinning Knowledge (Basic Syllabus) as set out in Annex 3 of the HSE statement on Radiation Protection Advisers.
Those wishing to use the course towards RPA certification can sit an optional marked short exam.
This is a CPD course approved by IPEM.
Provisional lecture list
Day 1: Review and effects of radiation
- Radiation protection framework
- Interactions and units
- Instrumentation
- Sources of exposure
- Risks and effects
- RP Culture & Ethics
Day 2: Statutory requirements
- IRR17
- IR(ME)R17
- Transport Regulations
- Other legislation and guidance
Day 3: Radiation protection in hospitals
- Diagnostic radiology RP in practice
- Radiotherapy RP in practice
- Nuclear Medicine RP in practice
- RPA case studies with worked examples
Day 4: The role of the RPA & Emergencies
- Radiation Incidents and Emergencies
- Giving Sound RPA Advice
- RPA certification
- Guest lecture
- Optional Assessment
Day 5: Non-Ionising radiation protection (optional)
- Microwave & RF
- Safety issues in MRI
- Ultrasound
- Medical lasers
Days 1–4 Workshops
- RPA Role play
- Risk assessments
- RPA Auditing
- RPA Case Studies
(The organisers may need to alter the final programme to fulfil practical commitments.)
Registration & Course fees
Downloadable Registration Form (PDF)
All current course registration fees are given on our registration form.
The cost includes lunches and light refreshments. Lecture notes and a certificate of attendance are provided. A course meal is included on the first evening of the course.
Please note – a discount applies to payments received by 20th February 2026.
You will be allocated a place on receipt of a completed registration form and a valid quoted payment reference/purchase order or completed bank transfer. We are unable to accept provisional bookings.
Early booking is advised as the number of participants is limited to provide a friendly open forum for debate and to assist in the running of the workshops. Applications from outside the UK are welcome.
Closing date for registrations – 3 April 2026
Related documents
Contacts
Course organiser: Dr Iain Murray (Royal Marsden Hospital)
Tel: +44 (0)20 8661 1440
For registration details and any other queries contact:
Course administrator: Mrs Jessica Keegan
Tel: +44 (0)20 8661 3075
Related pages
Latest ICR News
Blood test could spare men with advanced prostate cancer from futile chemotherapy
New research has identified a way to predict resistance to a cancer drug commonly used to treat advanced prostate cancer.
ICR researchers to contribute to £13.7m brain tumour research consortium
The NIHR has announced a £13.7 million investment into research to develop new brain tumour treatments in the UK. The funding will establish the NIHR Brain Tumour Research Consortium – a national partnership uniting hospitals, universities, cancer centres and charities, along with patients. This is a coordinated UK-wide effort, which will involve the ICR's scientists, aims to transform brain cancer treatment.
New structural insights reveal molecular details of a key step in cell cycle control
In a major advance for molecular biology and cancer research, scientists have uncovered the molecular mechanisms that control a key step during the activation of cyclin-dependent kinases (CDKs) – the master regulators of cell division.
Mapping myeloma mutations: study reveals why some drugs fail and others still work
A new study has shown that small genetic changes in a key protein can determine whether myeloma cells resist or respond to treatment – findings that could help clinicians choose more effective therapies for patients with this type of blood cancer.